UBS raised the firm’s price target on Intuitive Surgical to $316 from $314 and keeps a Neutral rating on the shares. Sales were modestly below expectations, and Intuitive saw lingering headwinds including the GLP1 impact to bariatric surgery, China anti-corruption driving slower system placements, and macro pressures on capital spending that could keep interest in a high-multiple stock more muted, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ISRG:
- Intuitive Surgical price target lowered to $340 from $373 at BTIG
- Intuitive Surgical price target lowered to $363 from $386 at Wells Fargo
- Intuitive Surgical price target lowered to $315 from $375 at Stifel
- Intuitive Surgical price target lowered to $312 from $320 at Baird
- Intuitive Surgical price target lowered to $390 from $400 at Citi
